NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

A Disease Registry of Patients With Mantle Cell Lymphoma
A Disease Registry of Patients With Mantle Cell Lymphoma

NCT03816683

CompletedN/A

Sponsor: AstraZeneca

Conditions: Mantle Cell Lymphoma

Countries: United States

The purpose of this study is to create a patient registry in order to assess treatment patterns, physician reported clinical outcomes and patient-reported health-related quality of life among patients diagnosed with Mantle Cell Lymphoma (MCL) who newly initiated a novel therapy in the past 6 months and whose treatment is ongoing at the time of enrollment.

Eligibility overview

Sex: ALL

Age: 18 Years to 130 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Patient diagnosed with Mantle Cell Lymphoma (MCL)
* Informed consent for participation
* Age ≥ 18 years old, as of the first observed diagnosis of MCL
* Patients for whom a clinical decision has been made to initiate novel therapy in the last 6 months, limited to the following novel agent categories:

  * Bcl-2 inhibitors
  * BTK inhibitors
  * Immunomodulatory agents
  * Phosphoinositide 3-kinase inhibitors The novel agent must have been granted approval in at least one haematological cancer. Treatment must be ongoing at the time of enrollment.

Exclusion Criteria:

• Patient is participating in a clinical study that prohibits participation in non-interventional studies, or where treatment is blinded, at the time of consent.
Locations (32)
  • Montgomery, Alabama, United States
  • Clovis, California, United States
  • Boulder, Colorado, United States
  • Jacksonville, Florida, United States
  • Pensacola, Florida, United States
  • Tampa, Florida, United States
  • Atlanta, Georgia, United States
  • Augusta, Georgia, United States
  • Chicago, Illinois, United States
  • Iowa City, Iowa, United States
  • Ann Arbor, Michigan, United States
  • Duluth, Minnesota, United States
  • Saint Louis Park, Minnesota, United States
  • Saint Paul, Minnesota, United States
  • Lincoln, Nebraska, United States
  • Berkeley Heights, New Jersey, United States
  • Hackensack, New Jersey, United States
  • East Syracuse, New York, United States
  • New York, New York, United States
  • Eugene, Oregon, United States
  • Danville, Pennsylvania, United States
  • Philadelphia, Pennsylvania, United States
  • Philadelphia, Pennsylvania, United States
  • Nashville, Tennessee, United States
  • Dallas, Texas, United States
  • Dallas, Texas, United States
  • Houston, Texas, United States
  • San Antonio, Texas, United States
  • Seattle, Washington, United States
  • Seattle, Washington, United States
  • + 2 more on CT.gov